Bladder cancer trials in Estonia
1 trial · From EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 4RecruitingResearch participation
A Rollover Study to Follow the Long-term Durability of Response to UGN-103 in Participants With Recurrent Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer (LG-IR-NMIBC) From Study BL013
- Where
- Pohja-Tallinna Linnaosa, Tartu Linn
- Age
- 18 years and over
- People
- 33 worldwide
- Run by
- Urogen Pharma Ltd.
See details and how to join2026-526359-75-00EU 2026-526359-75-00Registry updated 2026-09-15
All Bladder cancer trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.